Considerations on nosology for HIV-associated neurocognitive disorders: it is time to update?

Research output: Contribution to journalArticle

4 Citations (Scopus)


Aims: The prognosis and the clinical manifestations of HIV infection have changed with the introduction of the potent combination antiretroviral therapy (cART); however, up to 50% of patients meet research criteria for "HIV-associated neurocognitive disorders" (HAND) according with current nosology. The majority of patients affected by HAND, especially in cohorts with suppressed plasma viremia, showed an Asymptomatic Neurocognitive Impairment (ANI), without any functional impairment. After more than 10 years from the introduction of the current so-called "Frascati criteria", this mini-review aimed to address the emerging limitations in current diagnosis procedures. Methods: We discussed the most relevant literature on HAND prevalence, etiology, and diagnosis. Results: We addressed three main emerging issues: (1) the unclear clinical relevance of ANI entity; (2) the evidences that Frascati criteria could produce a significant overestimation of HAND; (3) the need to better identify patients with a higher risk to develop HAND requiring routine neuropsychological examinations. Conclusions: Frascati criteria should be updated to better respond to the present characteristics of HIV + cohorts and to help clinicians in their cognitive and global management.
Original languageEnglish
Pages (from-to)37-42
Number of pages6
Publication statusPublished - 2020


  • HIV
  • HIV-associated neurocognitive disorders
  • Nosology
  • Risk factors


Dive into the research topics of 'Considerations on nosology for HIV-associated neurocognitive disorders: it is time to update?'. Together they form a unique fingerprint.

Cite this